Episode Details
Back to Episodes
mRNA Flu Vaccine Gets FDA Approval | Pittsburgh News
Published 1 week, 4 days ago
Description
FDA just approved a groundbreaking mRNA flu vaccine for adults 50+, called mFLUSIVA, using the same tech as COVID shots. It’s faster to produce than traditional egg-based vaccines and could adapt quicker to new flu strains. Side effects are mild—pain, fatigue, headaches. Moderna plans more studies and aims for rollout in 2026-2027. A major leap forward for flu prevention, especially for seniors.
Listen in comfort:
Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn.
Advertise on DNN:
advertise@thednn.ai
This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.
View sources & latest updates:
https://sources.thednn.ai/5d3c08aeac23d128